(Q50988726)

26 March 2018

title

Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors (English)

1 reference

26 March 2018

0 references

Anna Kezerashvili

1 reference

26 March 2018

Himad Khattak

1 reference

26 March 2018

Aron Barsky

1 reference

26 March 2018

Reza Nazari

1 reference

26 March 2018

John D Fisher

1 reference

26 March 2018

publication date

1 April 2007

1 reference

26 March 2018

Journal of Interventional Cardiac Electrophysiology

published in

1 reference

26 March 2018

volume

1 reference

26 March 2018

issue

1 reference

26 March 2018

page(s)

243-246

1 reference

26 March 2018

The long QT syndrome. Prospective longitudinal study of 328 families

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10840-007-9124-Y

Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-007-9124-Y

QT prolongation associated with azithromycin/amiodarone combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-007-9124-Y

Torsade de pointes and cardiorespiratory arrest induced by azithromycin in a patient with congenital long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-007-9124-Y

Polymorphic ventricular tachycardia with a normal QT interval following azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10840-007-9124-Y

Is azithromycin treatment associated with prolongation of the Q-Tc interval?

21 January 2018

1 reference

12 December 2020

Impact of haemodialysis on QTc dispersion in children

1 reference

12 December 2020

Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes

1 reference

12 December 2020

Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation

1 reference

12 December 2020

QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion

1 reference

12 December 2020

Comparative safety of the different macrolides

1 reference

12 December 2020

A case of QT-interval prolongation precipitated by azithromycin

1 reference

12 December 2020

QT prolongation and Torsades de Pointes associated with clarithromycin

1 reference

12 December 2020

Cardiac actions of erythromycin: influence of female sex.

1 reference

12 December 2020

QT dispersion in patients with end-stage renal failure and during hemodialysis.

1 reference

12 December 2020

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.

1 reference

12 December 2020

Pharmacokinetics of azithromycin in normal and impaired renal function.

1 reference

12 December 2020

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

1 reference

12 December 2020

10.1007/S10840-007-9124-Y

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018